
Findings published in Cell Metabolism indicate that significantly reducing dietary methionine could slow the onset of inflammatory and autoimmune disorders such as multiple sclerosis in high-risk people. The research is based on immune cell studies by Van Andel Institute scientists.
The study concerns human nutrition and has no direct link to feed markets.
Human dietary research has little direct effect on feed commodity supply or demand. It is unlikely to move methionine or protein prices in the near term.
Not enough comparable past events yet for a historical read.
Moves of each commodity's benchmark from the last close before the event. Historical reads pool past events of the same kind; they describe what happened, not what will. Not investment advice.